Stephen R. Brady - Jun 21, 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Executive Officer, Director
Signature
/s/ Pierre Lorenzo, Attorney-in-Fact for Stephen R. Brady
Stock symbol
TPST
Transactions as of
Jun 21, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 04:29 PM
Previous filing
Jun 10, 2022
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +174K $0.00 174K Jun 21, 2022 Common Stock 174K $2.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.